drugset / Trial / NCT00141141

Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia

NCT00141141

Phase 4 Completed 383 enrolled Viatris Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of Atorvastin vs Simvastatin in decreasing LDL-C in diabetic subjects with hypercholesterolemia at the end of the treatment phase.

Timeline

Start
2004-01
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject Simvastatin Small molecule

Indications